New fund targets companies battered by market doubts
Record low biotech valuations have prompted a new VC investor to start shopping with a planned $200 million fund.
Source: afr.com
Chris Behrenbruch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chris Behrenbruch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chris Behrenbruch Today - Breaking & Trending Today
Australian biomedical developments for quadriplegics, and cancer
Australian companies have made significant progress in biomedical technologies to bring new remedies to people who need them most.
Source: thenewdaily.com.au
Dr Boreham's Crucible: Telix Pharmaceuticals
Telix Pharmaceuticals' prostate cancer imaging product Illucix is quickly conquering the USA, but management at the firm has (much) higher ambitions
Source: fnarena.com